期刊文献+

弓形虫多价疫苗研究近况 被引量:2

A review of Toxoplasma gondii multivalent vaccine
暂未订购
导出
摘要 弓形虫疫苗研制已经历了全虫疫苗、抗原组份疫苗、基因工程亚单位疫苗和核酸疫苗发展阶段,结果表明基因工程多价疫苗具有较大的前景。本文综述了弓形虫多价疫苗的研制中弓形虫抗原基因的筛选方法、表达载体的选择、研制方法及疫苗种类,并介绍了弓形虫多价疫苗的应用和目前存在的问题及解决策略。 The development of Toxoplasrna gondii vaccine has experienced the whole worm vaccines stage, antigen com ponents vaccine stage, gene engineering subunit vaccine stage, and nucleic acid vaccine stage. The results show that genetic en gineering multivalent vaccines have great prospects. In this paper, the preparation of Toxoplasma gondii multivalent vaccines are reviewed, including the method of selecting Toxoplasma antigen gene, the choice of expression vector, development of the method, and vaccines of the types. Meanwhile, it also reviews the application of Toxoplasma gondii multivalent vaccines and the existing problems and the solving strategy at present.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2013年第6期620-624,共5页 Chinese Journal of Zoonoses
基金 广西科学研究与技术开发计划项目(桂科攻10124001A-64)~~
关键词 弓形虫 疫苗 研究 Toxoplasma gondii vaccine research
  • 相关文献

参考文献24

  • 1McLeodR, Boyer K, Karrison T, et al. Outcome of treatmentfor congenital Toxoplasmosis, 1981-2004 : the National Collabo-rative Chicago-based, Congenital Toxoplasmosis Study [J]. ClinInfect Dis, 2006,42(10) : 1383-1394. DOI: 10. 1086/501360.
  • 2剡海阔,彭高辉,袁子国,朱兴全.抗弓形虫核酸疫苗的研究进展[J].中国人兽共患病学报,2009,25(10):1004-1007. 被引量:6
  • 3BoothroydJC,Dubremetz JF. Kiss and spit: the dual roles ofToxoplasma rhopries[J].Nat Rev Microbiol, 2008,6(1); 79-88. DOI: 10. I038/nrmicrol800.
  • 4DziadekB, Gatkowska J,Brzostek A, et al. Toxoplasma gon-dii :the immunogenic and protective efficacy of recombinantROP2 and ROP4 rhoptry proteins in murine experimental toxo-plasmosis[J]. Exp Parasitol, 2009,123(1): 81-89. DOI: 10.1016/j. exppara. 2009. 06. 002.
  • 5LiuMM, Yuan ZG, Peng GH, et al. Toxoplasma gondii mi-croneme protein 8(MIC8) is a potential vaccine candidate againsttoxoplasmosis [J ]. Parasitol Res, 2010, 106 (5 ): 1079-1084.DOI:10. 1007/s00436-010-1742-0.
  • 6李薇,刘玉和,刘波.弓形虫SAG1,ROP1基因及其复合抗原基因的核酸免疫研究[J].北华大学学报(自然科学版),2008,9(4):314-316. 被引量:4
  • 7李瑾,肖婷,黄炳成,仲维霞,修海迪,王英婷,韩广东,魏庆宽.弓形虫pcDNA3-p30-ROP2-HSP70复合核酸疫苗免疫保护性的研究[J].中国人兽共患病学报,2012,28(1):56-61. 被引量:10
  • 8ZhangJ, He SY, Jiang H, et al. Evaluation of the immune re-sponse induced by multiantigenic DNA vaccine encoding SAG1and ROP2of Toxoplasma gondii and the adjuvant properties ofmurineinterleukin-12 plasmid in BALB/c mice[J]. Parasitol Res,2007, 101(2): 331-338. DOI: 10. 1007/s00436-007-0465-3.
  • 9Lau YL,Thiruvengadam G,Lee WW, et al. Immunogeniccharacterization of the chimeric surface antigen 1 and 2 (SAG1/2) of Toxoplasma gondii expressed in the yeast Pichia pastoris[J]. Parasitol Res, 2011,109(3): 871-878. DOI: 10.1007/s00436-011-2315-6.
  • 10FangR, Feng HL, Nie N, et al. Construction and immunoge-nicity of pseudotype baculovirus expressing Toxoplasma gondiiSAG1 protein in BALB/c mice model [J]. Vaccine, 2010, 28(7):1803-1807. DOI: 10. 1016/j. vaccine. 2009. 12. 005.

二级参考文献132

共引文献94

同被引文献26

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部